<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/archiving/3.0/archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="hwp">jem</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19255146</article-id><article-id pub-id-type="publisher-id">20080954</article-id><article-id pub-id-type="doi">10.1084/jem.20080954</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Definitive Report</subject></subj-group></article-categories><title-group><article-title>Ly49P recognition of cytomegalovirus-infected cells expressing H2-D<sup>k</sup> and CMV-encoded m04 correlates with the NK cell antiviral response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kielczewska</surname><given-names>Agnieszka</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Pyzik</surname><given-names>Michal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Tianhe</given-names></name><xref ref-type="aff" rid="aff2">4</xref></contrib><contrib contrib-type="author"><name><surname>Krmpotic</surname><given-names>Astrid</given-names></name><xref ref-type="aff" rid="aff3">5</xref></contrib><contrib contrib-type="author"><name><surname>Lodoen</surname><given-names>Melissa B.</given-names></name><xref ref-type="aff" rid="aff2">4</xref></contrib><contrib contrib-type="author"><name><surname>Munks</surname><given-names>Michael W.</given-names></name><xref ref-type="aff" rid="aff4">6</xref></contrib><contrib contrib-type="author"><name><surname>Babic</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff3">5</xref></contrib><contrib contrib-type="author"><name><surname>Hill</surname><given-names>Ann B.</given-names></name><xref ref-type="aff" rid="aff4">6</xref></contrib><contrib contrib-type="author"><name><surname>Koszinowski</surname><given-names>Ulrich H.</given-names></name><xref ref-type="aff" rid="aff5">7</xref></contrib><contrib contrib-type="author"><name><surname>Jonjic</surname><given-names>Stipan</given-names></name><xref ref-type="aff" rid="aff3">5</xref></contrib><contrib contrib-type="author"><name><surname>Lanier</surname><given-names>Lewis L.</given-names></name><xref ref-type="aff" rid="aff2">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vidal</surname><given-names>Silvia M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">2</xref><xref ref-type="aff" rid="aff1">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Department of Human Genetics</institution>, <label>2</label><institution>McGill Centre for the Study of Host Resistance</institution>, <label>3</label><institution>Department of Microbiology and Immunology, McGill University, Montreal, Quebec, H3A 1B1, Canada</institution></aff><aff id="aff2"><label>4</label><institution>Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143</institution></aff><aff id="aff3"><label>5</label><institution>School of Medicine, University of Rijeka, HR-51 000 Rijeka, Croatia</institution></aff><aff id="aff4"><label>6</label><institution>Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239</institution></aff><aff id="aff5"><label>7</label><institution>Max von Pettenkofer-Institut, 80336 Munich, Germany</institution></aff><author-notes><corresp>CORRESPONDENCE Silvia M. Vidal: <email>silvia.vidal@mcgill.ca</email></corresp><fn><p>A. Kielczewska and M. Pyzik contributed equally to this paper. S. Jonjic, L.L. Lanier, and S.M. Vidal contributed equally to this paper.</p></fn></author-notes><pub-date pub-type="ppub"><day>16</day><month>3</month><year>2009</year></pub-date><volume>206</volume><issue>3</issue><fpage>515</fpage><lpage>523</lpage><history><date date-type="received"><day>1</day><month>5</month><year>2008</year></date><date date-type="accepted"><day>4</day><month>2</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Kielczewska et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/misc/terms.shtml">http://www.jem.org/misc/terms.shtml</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Natural killer (NK) cells are crucial in resistance to certain viral infections, but the mechanisms used to recognize infected cells remain largely unknown. Here, we show that the activating Ly49P receptor recognizes cells infected with mouse cytomegalovirus (MCMV) by a process that requires the presence of H2-D<sup>k</sup> and the MCMV m04 protein. Using H2 chimeras between H2-D<sup>b</sup> and -D<sup>k</sup>, we demonstrate that the H2-D<sup>k</sup> peptide-binding platform is required for Ly49P recognition. We identified m04 as a viral component necessary for recognition using a panel of MCMV-deletion mutant viruses and complementation of <italic>m04</italic>-deletion mutant (&#x00394;<italic>m04</italic>) virus infection. MA/My mice, which express Ly49P and H2-D<sup>k</sup>, are resistant to MCMV; however, infection with &#x00394;m04 MCMV abrogates resistance. Depletion of NK cells in MA/My mice abrogates their resistance to wild-type MCMV infection, but does not significantly affect viral titers in mice infected with &#x00394;<italic>m04</italic> virus, implicating NK cells in host protection through m04-dependent recognition. These findings reveal a novel mechanism of major histocompatability complex class I&#x02013;restricted recognition of virally infected cells by an activating NK cell receptor.</p></abstract></article-meta></front><body><p>Humans (<xref ref-type="bibr" rid="bib1">1</xref>) and mice (<xref ref-type="bibr" rid="bib2">2</xref>) lacking NK cells are vulnerable to certain viral infections. NK cells patrol for aberrant cells, which they eliminate through cytotoxic activity and secretion of cytokines (<xref ref-type="bibr" rid="bib3">3</xref>). NK cell activation depends on a complex array of inhibitory and activating receptors. Inhibitory receptors recognizing MHC class I molecules, including human killer cell immunoglobulin-like receptors (KIR) and mouse Ly49 receptors, play a predominant role. Both receptor families contain activating receptors, but the ligands are not well characterized. Viruses have devised numerous strategies to modulate the function of NK cells and have influenced the evolution of NK cell receptors.</p><p>The identification of mouse genes that protect from mouse cytomegalovirus (MCMV) infection has provided insights into the NK cell&#x02013;mediated control of viral proliferation. In C57BL/6 mice, NK cells expressing the activating Ly49H receptor that binds directly to m157, which is a MCMV-encoded cell surface glycoprotein (<xref ref-type="bibr" rid="bib3">3</xref>), control viral replication early after infection (<xref ref-type="bibr" rid="bib4">4</xref>). The essential role of Ly49H was confirmed by the transfer of MCMV resistance to genetically susceptible mice by <italic>Ly49h</italic> transgenesis (<xref ref-type="bibr" rid="bib5">5</xref>), whereas absence of <italic>Ly49h</italic> in C57BL/6 mice abolishes resistance (<xref ref-type="bibr" rid="bib6">6</xref>). Moreover, C57BL/6 mice are susceptible to MCMV mutants lacking <italic>m157</italic> (&#x00394;<italic>m157</italic>) (<xref ref-type="bibr" rid="bib7">7</xref>). Collectively, these data demonstrated the importance of activating NK cell receptor&#x02013;specific recognition of a virus-encoded ligand in host resistance.</p><p>Despite lacking <italic>Ly49h</italic>, MA/My mice are resistant to MCMV (<xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib9">9</xref>), which depends on the specific combination of MA/My alleles at <italic>Ly49</italic> and MHC loci. The activating receptor Ly49P in MA/My mice recognizes MCMV-infected cells, and Ly49P-dependent activation is abrogated by an anti&#x02013;H2-D<sup>k</sup> antibody (<xref ref-type="bibr" rid="bib9">9</xref>). These results suggested that MA/My resistance is conferred by NK cell&#x02013;mediated recognition of infected cells by a mechanism involving Ly49P, H2-D<sup>k</sup>, and an additional molecule expressed during MCMV infection.</p><p>CMVs possess numerous genes dedicated to manipulating the host immune response. Three MCMV gene products alter host MHC class I expression: m04, m06, and m152 (<xref ref-type="bibr" rid="bib10">10</xref>). m152 retains peptide-loaded MHC class I in the endoplasmic reticulum cis-Golgi intermediate compartment (<xref ref-type="bibr" rid="bib11">11</xref>). m04 and m06 carry cytoplasmic (CT) motifs involved in cargo-sorting pathways; m06 redirects MHC class I to the late endosome&#x02013;lysosome pathway for degradation, thus preventing antigen presentation (<xref ref-type="bibr" rid="bib12">12</xref>). m04 associates with MHC class I in the ER, and these complexes travel to the cell surface (<xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib14">14</xref>); however, m04 does not down-regulate MHC class I.</p><p>Here, we found that Ly49P recognition depends on the following: H2-D<sup>k</sup> expression on the infected cell, the peptide-binding groove of H2-D<sup>k</sup>, and m04. Infection of MA/My mice with a <italic>m04</italic>-deletion MCMV mutant resulted in increased susceptibility, suggesting that Ly49P-mediated NK cell recognition of H2-D<sup>k</sup> complexed with m04 on the infected cell is necessary to attenuate virus replication.</p><sec><title>RESULTS AND DISCUSSION</title><sec><title>H2-D<sup>k</sup> is necessary for Ly49P recognition of MCMV-infected cells</title><p>In view of MCMV's interference with host MHC class I expression, we examined whether sufficient amounts of H2 are expressed on the surface of infected cells to permit recognition by Ly49P (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). BALB.K mouse embryonic fibroblasts (MEFs) were infected with MCMV expressing GFP (<xref ref-type="bibr" rid="bib15">15</xref>), followed by staining with anti&#x02013;H2-D<sup>k</sup> or anti&#x02013;H2-K<sup>k</sup> antibodies (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). Flow cytometric analysis revealed populations of cells that were noninfected (GFP-negative), mildly infected (GFP-dim), and highly infected (GFP-bright). We observed increased MHC class I expression on the GFP-negative cells, likely caused by up-regulation by type I IFN secreted by virus-infected cells. Importantly, GFP-dim MCMV-infected cells expressed H2-D<sup>k</sup> and -K<sup>k</sup> on their surface (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). Therefore, MHC class I expression is diminished, but not totally ablated, in MCMV-infected cells (<xref ref-type="bibr" rid="bib16">16</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p><bold>Activation via Ly49P requires H2-D<sup>k</sup>.</bold> (A) H2<sup>k</sup> proteins were detected on MCMV-infected cells. BALB.K MEFs were infected with GFP-MCMV (MOI 0.5 and 0.1) and stained with mAbs against: H2-D<sup>k</sup>, H2-K<sup>k</sup>, or an isotype-matched control antibody. GFP-DIM MCMV-infected cells expressing H2-D<sup>K</sup> and H2-K<sup>K</sup> molecules are shown in circles. (B) NIH3T3 cells were transduced with <italic>H2<sup>k</sup></italic>-encoding retroviruses and their surface expression was analyzed. BALB.K MEFs were a positive control. (C) NKL-Ly49P cells were co-cultured with uninfected (white bars) or MCMV-infected (black bars) cells. MCMV-infected or uninfected MEF.K, NIH3T3 cells (&#x000d8;), or NIH3T3 cells transduced with H2-D<sup>k</sup> and/or -K<sup>k</sup> were used as stimulators. IFN-&#x003b3; was detected by ELISA. (D) NKL-Ly49H cells were a positive control. Data are representative of four independent experiments. Error bars represent the SD.</p></caption><graphic xlink:href="JEM_20080954_GS_Fig1"/></fig><p>Activation of Ly49P-expressing NFAT-GFP reporter cells co-cultured with MCMV-infected <italic>H2<sup>k</sup></italic> MEFs is abolished by anti&#x02013;H2-D<sup>k</sup>, but not anti&#x02013;H2-K<sup>k</sup>, blocking antibodies (<xref ref-type="bibr" rid="bib9">9</xref>). We transduced NIH3T3 cells, which endogenously carry <italic>H2<sup>q2</sup></italic>, with H2-D<sup>k</sup> and/or -K<sup>k</sup>, and assessed surface expression (<xref ref-type="fig" rid="fig1">Fig. 1 B</xref>). None of the transduced cells stimulated a human NK cell line transduced with Ly49P (NKL-Ly49P) to secrete INF-&#x003b3; in the absence of infection (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>). However, when infected with MCMV, cells expressing H2-D<sup>k</sup> stimulated NKL-Ly49P cells to produce IFN-&#x003b3; (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>). Ly49H-expressing NKL (NKL-Ly49H) cells secreted INF-&#x003b3; when co-cultured with MCMV-infected cells, irrespective of H2 expression (<xref ref-type="fig" rid="fig1">Fig. 1 D</xref>). Therefore, H2-D<sup>k</sup>, but not H2-K<sup>k</sup>, is necessary for Ly49P activation in the presence of infection.</p></sec><sec><title>&#x003b1;1&#x003b1;2 domains of H2-D<sup>k</sup> are necessary for Ly49P recognition</title><p>MHC class I molecules consist of a heavy chain with &#x003b1;1, &#x003b1;2, and &#x003b1;3 domains associated with &#x003b2;<sub>2</sub>-microglobulin (&#x003b2;<sub>2</sub>m). The peptide-binding platform is composed of two parallel &#x003b1; helices positioned on top of a &#x003b2;-plated sheet, formed by the &#x003b1;1 and &#x003b1;2 domains. To determine which domains of H2-D<sup>k</sup> are recognized by Ly49P, we generated chimeras by swapping domains between H2-D<sup>k</sup> and H2-D<sup>b</sup> (<xref ref-type="fig" rid="fig2">Fig. 2 A</xref>). &#x003b1;1 and &#x003b1;2 from H2-D<sup>b</sup> were fused with the &#x003b1;3, transmembrane (TM), and CT domains of H2-D<sup>k</sup> (D<sup>b</sup><sub>&#x003b1;1&#x003b1;2</sub>D<sup>k</sup><sub>&#x003b1;3</sub>). &#x003b1;1, &#x003b1;2, and &#x003b1;3 from H2-D<sup>b</sup> were fused with the TM and CT domains of H2-D<sup>k</sup> (D<sup>b</sup><sub>&#x003b1;1&#x003b1;2&#x003b1;3</sub>D<sup>k</sup>). &#x003b1;1 and &#x003b1;2 from H2-D<sup>k</sup> were fused with the &#x003b1;3, TM, and CT domains of H2-D<sup>b</sup> (D<sup>k</sup><sub>&#x003b1;1&#x003b1;2</sub> D<sup>b</sup><sub>&#x003b1;3</sub>). &#x003b1;1, &#x003b1;2, and &#x003b1;3 from H2-D<sup>k</sup> were fused with the TM and CT domains of H2-D<sup>b</sup> (D<sup>k</sup><sub>&#x003b1;1&#x003b1;2&#x003b1;3</sub>D<sup>b</sup>). Chimeric proteins were expressed in high amounts on the surface of NIH3T3 cells (<xref ref-type="fig" rid="fig2">Fig. 2 B</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><p><bold>&#x003b1;1&#x003b1;2 of H2-D<sup>k</sup> are necessary for Ly49P recognition.</bold> (A) Schematic representation. H2-D<sup>k</sup> is represented in gray, H2-D<sup>b</sup> in white, and &#x003b2;<sub>2</sub>m as white dotted circle. (B) Surface expression of the native H2 and chimeras on NIH3T3 cells was assayed using antibodies against the &#x003b1;1&#x003b1;2 domains of H2-D<sup>k</sup> and/or -D<sup>b</sup>. (C) NKL-Ly49P cells were co-cultured with uninfected (white bars) or MCMV-infected (black bars) cells. MCMV-infected or uninfected NIH3T3 cells expressing native H2 or chimeras were stimulators. Significant (P &#x0003c; 0.01) activation of NKL-Ly49P cells depended on the presence of &#x003b1;1&#x003b1;2 domains of H2-D<sup>k</sup> on MCMV-infected cells. (D) NKL-Ly49H cells were a control. Data are representative of three independent experiments.</p></caption><graphic xlink:href="JEM_20080954_GS_Fig2"/></fig><p>These cells, which were infected or not infected with MCMV, were used to stimulate NKL-Ly49H or NKL-Ly49P cells. None of the uninfected cells induced significant amounts of IFN-&#x003b3; secretion. In contrast, MCMV-infected cells expressing H2-D<sup>k</sup>, but not H2-D<sup>b</sup>, activated the NKL-Ly49P cells (<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>). When &#x003b1;1 and &#x003b1;2 of H2-D<sup>k</sup> were replaced with those of H2-D<sup>b</sup>, NKL-Ly49P cells were not stimulated (<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>). Interestingly, when &#x003b1;1 and &#x003b1;2 of H2-D<sup>b</sup> were replaced by those of -D<sup>k</sup>, infected cells stimulated significantly higher amounts of IFN-&#x003b3; from NKL-Ly49P cells (P &#x0003c; 0.01; <xref ref-type="fig" rid="fig2">Fig. 2 C</xref>). Thus, the peptide-binding platform specified by &#x003b1;1 and &#x003b1;2 of H2-D<sup>k</sup> is necessary for activating Ly49P recognition. The same region is important for contact between inhibitory Ly49 receptors and their MHC class I ligands (<xref ref-type="bibr" rid="bib17">17</xref>).</p></sec><sec><title>m04 is critical for Ly49P recognition</title><p>MCMV genes involved in the manipulation of MHC class I might be involved in recognition by Ly49P. We tested MCMV deletion mutant viruses lacking members of the <italic>m145</italic> (&#x00394;<italic>m144-158</italic>, &#x00394;<italic>m151-158</italic>, &#x00394;<italic>m151-165</italic>, &#x00394;<italic>m152</italic>, and &#x00394;<italic>m157</italic>) and the <italic>m02</italic> (&#x00394;<italic>m1-22</italic>) gene families, including the <italic>m04</italic> and <italic>m06</italic> genes. Infected MEFs were used to stimulate Ly49P or Ly49H NFAT-GFP reporter cells. Absence of the <italic>m145</italic> family did not affect Ly49P recognition (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). As expected, Ly49H reporters did not respond to MEFs infected with mutants lacking <italic>m157</italic> (<xref ref-type="fig" rid="fig3">Fig. 3</xref>) (<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib18">18</xref>). Although deletion of the <italic>m1-22</italic> region did not affect Ly49H recognition, it completely abolished Ly49P reporter cell activation. We also assayed deletion mutants lacking <italic>m04</italic> (&#x00394;<italic>m04</italic>), <italic>m06</italic> (&#x00394;<italic>m06</italic>), and/or <italic>m152</italic> (&#x00394;<italic>m152</italic>). Deletion of <italic>m04</italic>, but not <italic>m06</italic> or <italic>m152</italic>, completely abrogated Ly49P-mediated activation (<xref ref-type="fig" rid="fig3">Fig. 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><p><bold>Ly49P-mediated recognition requires m04.</bold> Ly49P or Ly49H NFAT-GFP reporter cells were co-cultured with MEF.K infected with MCMV-deletion mutants and GFP expression was assessed (shaded histograms, infected; open histograms, uninfected). Data are representative of four independent experiments.</p></caption><graphic xlink:href="JEM_20080954_GS_Fig3"/></fig></sec><sec><title>m04 complements &#x00394;m04 MCMV in Ly49P-mediated activation</title><p>To determine whether m04 protein is sufficient to activate Ly49P reporter cells, we transiently transfected <italic>m04</italic> into immortalized MEF.K cells. When <italic>m04</italic>-transfected MEF.K cells were used to stimulate Ly49P-NFAT-GFP reporters, no significant activation was detected (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref>). Ly49P-mediated recognition was rescued when <italic>m04</italic>-transfected cells were infected with &#x00394;<italic>m04</italic> MCMV. <italic>m90</italic> and <italic>m157</italic> failed to complement &#x00394;<italic>m04</italic> MCMV infection (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref>). Thus, <italic>m04</italic> is necessary, but not sufficient, for Ly49P recognition.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><p><bold>m04 complements &#x00394;<italic>m04</italic> MCMV infection in Ly49P reporter cell assays.</bold> (A) Transient <italic>m04</italic> transfection complements the &#x00394;<italic>m04</italic> viral infection in the Ly49P reporter assays. Ly49P reporter cells were co-cultured with MEF.K either untransfected or transfected with <italic>m04</italic> (+m04), <italic>m90</italic> (+m90), or <italic>m157</italic> (+m157). Stimulators were uninfected or infected with WT or &#x00394;<italic>m04</italic> MCMV. (B) Stable m04 expression complements the &#x00394;<italic>m04</italic> viral infection in the Ly49P reporter assays. Ly49P reporter cells were co-cultured with mRFP (+mRFP) or V5-m04 (+V5-m04) positive MEF.K cells. Stimulators were treated as in A. The histogram shows mRFP expression in mRFP-MEF.K cells (black) and untransduced cells (gray). (C) H2<sup>k</sup> and V5-m04 are expressed on the surface of MCMV-infected cells. Uninfected and WT or &#x00394;<italic>m04</italic> MCMV-infected V5-m04 MEF.K cells used in the reporter assay shown in (B) were costained with anti-H2-D<sup>k</sup>, anti-V5, and anti-m06. Plots represent live-gated cells. (D) Top histograms display V5-m04 expression (black) in uninfected V5-m04 MEF.K (left) and V5-m04 NIH3T3-H2-D<sup>k</sup> cells (right), compared with untransfected cells (gray). Middle and bottom histograms display WT or &#x00394;<italic>m04</italic> MCMV-infected cells gated on the top right (D<sup>k+</sup>m06<sup>+</sup>) and bottom right (D<sup>k+</sup>m06<sup>&#x02212;</sup>) quadrants of untransfected MEF.K (gray) and V5-m04 MEF.K (black) cells. The percentage of V5-m04<sup>+</sup> cells in each gated population is indicated. Data are representative of three independent experiments.</p></caption><graphic xlink:href="JEM_20080954_GS_Fig4"/></fig><p>To verify m04 expression, we transduced MEF.K with a V5-tagged <italic>m04</italic> and sorted V5-m04&#x02013;expressing cells (V5-m04 MEF.K). As a control, we transduced MEF.K with a monomeric red fluorescent protein (mRFP-MEF.K). Uninfected cells did not activate the Ly49P-NFAT-GFP reporters (<xref ref-type="fig" rid="fig4">Fig. 4 B</xref>). In contrast to mRFP-MEF.K, &#x00394;<italic>m04</italic> MCMV infection of V5-m04-MEF.K stimulated reporter cells at levels comparable to WT MCMV. Using FACS, we confirmed the presence of V5-m04 and H2-D<sup>k</sup> on the cell surface, and distinguished infected cells by intracellular anti-m06 staining (<xref ref-type="fig" rid="fig4">Fig. 4 C</xref>). H2-D<sup>k</sup> was expressed on the surface of &#x0223c;20% of the cells infected with mutant or WT virus. To examine V5-m04 expression during infection, we gated cells based on H2-D<sup>k</sup> and m06 expression (Dk<sup>&#x02212;</sup>m06<sup>+</sup>, Dk<sup>+</sup>m06<sup>+</sup>, and Dk<sup>+</sup>m06<sup>&#x02212;</sup>; <xref ref-type="fig" rid="fig4">Fig. 4 D</xref>). Consistent with reports of the association of m04 with H2 (<xref ref-type="bibr" rid="bib19">19</xref>), we observed a clear correlation between V5-m04 and H2-D<sup>k</sup> (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>). The largest frequency of V5-m04&#x02013;expressing cells and the highest amounts of V5-m04 were seen on Dk<sup>+</sup>m06<sup>+</sup> cells, demonstrating coexpression of V5-m04 and H2-D<sup>k</sup> at the surface of infected cells. These results suggest that a factor in addition to m04 protein and H2-D<sup>k</sup> in the infected cell is required for Ly49P-dependent recognition.</p><p>m04 is physically associated with H2 molecules. Peptide-loading facilitates m04&#x02013;H2 complex formation, and &#x003b2;<sub>2</sub>m is essential (<xref ref-type="bibr" rid="bib19">19</xref>). Our results confirm that m04&#x02013;H2 complexes are present on the cell surface and available for Ly49P recognition. However, m04 must play a role other than simply increasing the expression of MHC class I because Ly49P reporter cells were unresponsive to uninfected MEFs treated with type I IFN to increase H2 expression (<xref ref-type="bibr" rid="bib9">9</xref>). m04 might cause an allosteric change in H2-D<sup>k</sup>, thereby permitting interactions with Ly49P. However, expression of m04 in MCMV-infected fibroblasts does not affect stimulation of cytotoxic T cells, indicating native H2 folding and recognition (<xref ref-type="bibr" rid="bib20">20</xref>). Alternatively, m04 might provide a specific peptide recognized by Ly49P in a H2-D<sup>k</sup>&#x02013;dependent manner. Although it remains to be determined whether m04 peptides are involved in Ly49P recognition, this might not be the case because MEF.K transfected with m04 failed to stimulate the Ly49P reporters in the absence of infection. m04 associates via its TM domain with H2 independently of MCMV infection. However, in uninfected cells, export of m04&#x02013;H2 complexes to the cell surface is less efficient (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>) (<xref ref-type="bibr" rid="bib19">19</xref>). Thus, other infection-induced proteins might be required for assembly or transport of H2-D<sup>k</sup>&#x02013;m04 complexes to the surface of infected cells for recognition by Ly49P.</p></sec><sec><title>m04 is critical for MCMV resistance in MA/My mice</title><p>Initially, m04 was proposed to inhibit NK cell activation, thereby favoring viral replication (<xref ref-type="bibr" rid="bib13">13</xref>). Conversely, our results suggest that m04 activates Ly49P-bearing NK cells, benefiting host defense. To evaluate the role of m04 in vivo, we infected MA/My mice with WT or &#x00394;<italic>m04</italic> MCMV and measured viral load (<xref ref-type="fig" rid="fig5">Fig. 5 A</xref>). 4 d after infection (a.i.), mice infected with WT MCMV had a 100-fold lower viral titer in the spleen and liver than mice infected with &#x00394;<italic>m04</italic> MCMV. Thus, removal of <italic>m04</italic> from MCMV genome diminishes MA/My resistance.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><p><bold><italic>m04</italic> deletion abrogates NK-cell mediated MA/My resistance</bold>. (A) MA/My mice were infected with 5 &#x000d7; 10<sup>5</sup> PFU of WT or &#x00394;<italic>m04</italic> MCMV. 4 d a.i., viral loads in the spleen and liver were assessed. (B) MA/My and B6 mice were either untreated or depleted of NK cells 48 h before infection. 4 d a.i., viral titers in the spleen were assessed. Three to four mice per group were used. Data are representative of three independent experiments.</p></caption><graphic xlink:href="JEM_20080954_GS_Fig5"/></fig><p>To determine the role of NK cells, MA/My mice were depleted of NK cells with anti-NK1.1 mAb. Splenic viral titers in untreated or NK cell&#x02013;depleted MA/My mice infected with &#x00394;<italic>m04</italic> MCMV were equivalent (<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>). In contrast, untreated C57BL/6 mice infected with &#x00394;<italic>m04</italic> MCMV showed a low viral load, equivalent to infection with WT MCMV, whereas NK cell&#x02013;depleted C57BL/6 mice had a high viral burden when infected with either &#x00394;<italic>m04</italic> or WT MCMV (<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>). Although neutralizing antibodies against Ly49P are not available to formally prove that Ly49P-bearing NK cells are responsible for resistance, our studies strongly support a role for Ly49P&#x02013;H2-D<sup>k</sup>&#x02013;m04 axis in the NK cell&#x02013;mediated control of MCMV.</p></sec><sec><title>Concluding remarks</title><p>MCMV resistance in F<sub>2</sub> crosses between MCMV-resistant MA/My and MCMV-susceptible BALB/c mice indicated that only mice homozygous for <italic>Ly49</italic> and <italic>H2<sup>k</sup></italic> MA/My-derived alleles were resistant to MCMV (<xref ref-type="bibr" rid="bib9">9</xref>). We identified <italic>Ly49p</italic> as the most likely gene involved in resistance based on: (a) its genetic location, (b) its absence in <italic>H2<sup>k</sup></italic> MCMV-susceptible mice, and (c) its recognition of MCMV-infected cells using Ly49P reporter cell assays. Although the importance of the <italic>H2<sup>k</sup></italic> haplotype for MCMV resistance was established previously, the precise mechanism had not been determined (<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib21">21</xref>). Here, we demonstrate that the peptide-binding &#x003b1;1 and &#x003b1;2 platform of H2-D<sup>k</sup> is an absolute prerequisite for Ly49P recognition. Moreover, this recognition and NK cell&#x02013;dependent resistance in MA/My mice is dependent on <italic>m04</italic>.</p><p>MCMV isolates from wild mice indicate that the <italic>m04</italic> gene is very polymorphic, like <italic>m157</italic> (<xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref>). Variation in <italic>m157</italic> is viewed as a result of the strong selective pressure applied by Ly49H<sup>+</sup> NK cells, as demonstrated by a high rate of mutations in <italic>m157</italic> isolated from MCMV passaged in <italic>Ly49h</italic>-bearing mice (<xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref>). Most m04 variation falls in the extracellular domain (<xref ref-type="bibr" rid="bib26">26</xref>), which might influence the binding of Ly49P, suggesting that <italic>m04</italic> polymorphisms emerge to escape NK cells.</p><p>Retention of a viral protein that enhances the killing of infected cells is counterintuitive, yet m04 might be beneficial for the virus. For example, through the stabilization of H2 on the surface of infected cells, m04 might render H2-D<sup>k</sup> more accessible to inhibitory receptors and suppress NK cell activation in certain mouse strains. This has been proposed for m157, which is recognized not only by Ly49H but also by a closely related inhibitory receptor, Ly49I (<xref ref-type="bibr" rid="bib18">18</xref>). Alternatively, m04 might confer host survival and thereby increase virus dissemination in the population, as proposed for <italic>B15R</italic> in vaccinia virus, which encodes a soluble IL-1 receptor. Deletion of <italic>B15R</italic> increases mortality in mice, suggesting that the viral blockade of IL-1&#x003b2; diminishes the acute phase response and modulates severity of the disease (<xref ref-type="bibr" rid="bib27">27</xref>). Regulation of antigen presentation by m04, in concert with m06 and m152, might influence the adaptive immune response to the virus' benefit (<xref ref-type="bibr" rid="bib28">28</xref>). Regardless of how m04 evolved, the increased viral titers observed in MA/My mice infected with &#x00394;<italic>m04</italic> MCMV demonstrate that m04 is crucial for effective NK cell&#x02013;mediated control of viral replication. Given the fact that intact or NK cell&#x02013;depleted MA/My mice infected with &#x00394;<italic>m04</italic> MCMV had similar viral titers, it seems that recognition of m04 is responsible for most of the NK cell&#x02013;mediated protective effect.</p><p>The Ly49P&#x02013;H2-D<sup>k</sup>&#x02013;m04 model system provides new perspectives in understanding the relationship between KIR and HLA in human disease. Genetic epidemiological studies have identified several combinations of KIR and MHC loci associated with resistance to HIV and hepatitis C virus (<xref ref-type="bibr" rid="bib29">29</xref>); however, the molecular interactions responsible for these events remain unresolved. Our studies highlight the significance of activating NK cell receptor&#x02013;MHC class I interactions in recognition of infection, warranting further investigation of their role in host resistance to other pathogens.</p></sec></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Mice</title><p>Mice were purchased at The Jackson Laboratory. Animal protocols or experiments were approved by Canadian Council on Animal Care (CCAC) and McGill University Animal Resources Center.</p></sec><sec><title>Virus</title><p>&#x00394;<italic>m04</italic>&#x00394;<italic>m06</italic>, &#x00394;<italic>m04</italic>&#x00394;<italic>m152</italic>, &#x00394;<italic>m06</italic>&#x00394;<italic>m152</italic>, &#x00394;<italic>m04</italic>&#x00394;<italic>m06</italic>&#x00394;<italic>m152</italic>, &#x00394;<italic>m144</italic>-<italic>158</italic>, &#x00394;<italic>m01-22</italic>, &#x00394;<italic>m151-m165</italic> (DMS94.5), &#x00394;<italic>m151-m158</italic> (MC96.73), and WT BAC-derived (MW97.01) viruses were previously described (<xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib30">30</xref>&#x02013;<xref ref-type="bibr" rid="bib33">33</xref>). 6&#x02013;8-wk-old mice were infected i.p. with 5 &#x000d7; 10<sup>3</sup> PFU/mouse. Viruses were quantified by plaque assays (<xref ref-type="bibr" rid="bib9">9</xref>). For NK cell depletion, mice were injected i.v. with 150 &#x000b5;g anti-NK1.1 (PK136) mAb 48 h before infection.</p></sec><sec><title>Cells</title><sec><title>Reporters.</title><p>Ly49P- and Ly49H-transduced 2B4 NFAT-GFP reporter cells were previously described (<xref ref-type="bibr" rid="bib9">9</xref>). NKL cells (gift from M. Robertson, Indiana University, Bloomington, IN) (<xref ref-type="bibr" rid="bib34">34</xref>) were transduced with Ly49P<sup>MA/My</sup> or Ly49H<sup>C57BL/6</sup> in pMx-puro (gift from T. Kitamura, University of Tokyo, Tokyo, Japan) (<xref ref-type="bibr" rid="bib18">18</xref>).</p></sec><sec><title>Stimulators.</title><p>Primary BALB.K MEFs were prepared as previously described (<xref ref-type="bibr" rid="bib9">9</xref>). BALB.K MEFs were immortalized (MEF.K) with polyoma large T antigen (gift from M. Fried, University of California, San Francisco, San Francisco, CA). H2-D<sup>k</sup>, H2-D<sup>b</sup>, or recombinant H2 cDNA in pMx-puro were used to transduce NIH3T3 cells. MEF.K were transiently transfected with pMx-puro containing <italic>m04</italic> (<xref ref-type="bibr" rid="bib35">35</xref>), <italic>m157</italic>, or <italic>m90</italic>. <italic>m04</italic> lacking its endogenous leader sequence was cloned into pMx-neo that contains a human CD8 leader, followed by a V5 tag. mRFP cDNA was cloned into pMx-puro. MEF.K or NIH3T3-D<sup>k</sup> cells were infected and sorted for high expression by flow cytometry.</p></sec><sec><title>Flow cytometry</title><p>MEF.K infected by GFP-MCMV (MOI 0.5 or 0.1) for 48 h were stained with biotin-conjugated anti&#x02013;H2-D<sup>k</sup> (15&#x02013;5-5, ATCC) or anti-H2-K<sup>k</sup> (16&#x02013;3-22, ATCC), followed by APC-conjugated streptavidin (BD). NIH3T3 cells stably expressing H2-D<sup>k</sup>, -K<sup>k</sup>, -D<sup>b</sup>, or chimeras were stained with FITC-conjugated anti&#x02013;H2-D<sup>k</sup>, &#x02013;H2-K<sup>k</sup>, or &#x02013;H2-D<sup>b</sup> (28&#x02013;14-8; BD). Infected (MOI 0.5) or uninfected MEF.K, V5-m04 MEF.K, or V5-m04 NIH3T3-D<sup>k</sup> cells were detached 24 h a.i., blocked with anti-CD16/CD32 mAb (eBioscience), and stained with anti-V5 (V5-10; Sigma-Aldrich), PE-conjugated donkey anti&#x02013;mouse IgG (eBioscience), biotin-conjugated anti-H2-D<sup>k</sup>, and APC-conjugated streptavidin. Cells were fixed, permeabilized, and stained with Alexa Fluor 488&#x02013;conjugated anti-m06 antibody (CROMA 229) (<xref ref-type="bibr" rid="bib36">36</xref>). Cells were analyzed on a FACSCalibur (BD).</p></sec><sec><title>Reporter assay</title><p>Stimulator cells were infected (MOI 0.5 or 1) with MCMV or MCMV-deletion mutants for 22 h. NFAT-GFP reporter cells were co-cultured overnight with stimulators in 48-well plates at a 1:1 ratio and analyzed by flow cytometry. NKL reporter cells were co-cultured overnight with stimulators at 5:1 ratio in 96-well plates, and IFN-&#x003b3; was measured by ELISA (eBioscience).</p></sec><sec><title>Statistics</title><p>Differences between groups were calculated with two-way ANOVA analysis assuming not-repeated measures, followed by Bonferroni after tests. Results with P &#x0003c; 0.05 were considered significant.</p></sec></sec></sec></body><back><ack><p>Supported by Canadian Institutes of Health Research MOP-7781 (S.M. Vidal); National Institutes of Health AI068129 (L.L. Lanier), Croatian Ministry of Science, Education, and Sport 062-0621261-1263, and National Institutes of Health HD044721 (S. Jonjic). T. Sun is a Cancer Research Institute fellow. A. Kielczewska is supported by McGill Majors Fellowship. M. Pyzik is supported by CIHR Doctoral Award. A. Krmpotic is supported by the Howard Hughes Medical Institute Scholars grant. L.L. Lanier is an American Cancer Society Research Professor. S.M. Vidal is a Canada Research Chair.</p><p>The authors have no conflicting financial interests.</p></ack><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>C.A.</given-names></name><name><surname>Byron</surname><given-names>K.S.</given-names></name><name><surname>Sullivan</surname><given-names>J.L.</given-names></name></person-group><year>1989</year><article-title>Severe herpesvirus infections in an adolescent without natural killer cells</article-title>.<source>N. Engl. J. Med.</source><volume>320</volume>:<fpage>1731</fpage>&#x02013;<lpage>1735</lpage><pub-id pub-id-type="pmid">2543925</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shellam</surname><given-names>G.R.</given-names></name><name><surname>Allan</surname><given-names>J.E.</given-names></name><name><surname>Papadimitriou</surname><given-names>J.M.</given-names></name><name><surname>Bancroft</surname><given-names>G.J.</given-names></name></person-group><year>1981</year><article-title>Increased susceptibility to cytomegalovirus infection in beige mutant mice</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>78</volume>:<fpage>5104</fpage>&#x02013;<lpage>5108</lpage><pub-id pub-id-type="pmid">6272291</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><year>2008</year><article-title>Evolutionary struggles between NK cells and viruses</article-title>.<source>Nat. Rev. Immunol.</source><volume>8</volume>:<fpage>259</fpage>&#x02013;<lpage>268</lpage><pub-id pub-id-type="pmid">18340344</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scalzo</surname><given-names>A.A.</given-names></name><name><surname>Fitzgerald</surname><given-names>N.A.</given-names></name><name><surname>Simmons</surname><given-names>A.</given-names></name><name><surname>La Vista</surname><given-names>A.B.</given-names></name><name><surname>Shellam</surname><given-names>G.R.</given-names></name></person-group><year>1990</year><article-title>Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen</article-title>.<source>J. Exp. Med.</source><volume>171</volume>:<fpage>1469</fpage>&#x02013;<lpage>1483</lpage><pub-id pub-id-type="pmid">2159050</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Zafer</surname><given-names>A.</given-names></name><name><surname>de Repentigny</surname><given-names>Y.</given-names></name><name><surname>Kothary</surname><given-names>R.</given-names></name><name><surname>Tremblay</surname><given-names>M.L.</given-names></name><name><surname>Gros</surname><given-names>P.</given-names></name><name><surname>Duplay</surname><given-names>P.</given-names></name><name><surname>Webb</surname><given-names>J.R.</given-names></name><name><surname>Vidal</surname><given-names>S.M.</given-names></name></person-group><year>2003</year><article-title>Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice</article-title>.<source>J. Exp. Med.</source><volume>197</volume>:<fpage>515</fpage>&#x02013;<lpage>526</lpage><pub-id pub-id-type="pmid">12591908</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fodil-Cornu</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Belanger</surname><given-names>S.</given-names></name><name><surname>Makrigiannis</surname><given-names>A.P.</given-names></name><name><surname>Biron</surname><given-names>C.A.</given-names></name><name><surname>Buller</surname><given-names>R.M.</given-names></name><name><surname>Vidal</surname><given-names>S.M.</given-names></name></person-group><year>2008</year><article-title>Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex</article-title>.<source>J. Immunol.</source><volume>181</volume>:<fpage>6394</fpage>&#x02013;<lpage>6405</lpage><pub-id pub-id-type="pmid">18941230</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bubic</surname><given-names>I.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Krmpotic</surname><given-names>A.</given-names></name><name><surname>Saulig</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Yokoyama</surname><given-names>W.M.</given-names></name><name><surname>Jonjic</surname><given-names>S.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>2004</year><article-title>Gain of virulence caused by loss of a gene in murine cytomegalovirus</article-title>.<source>J. Virol.</source><volume>78</volume>:<fpage>7536</fpage>&#x02013;<lpage>7544</lpage><pub-id pub-id-type="pmid">15220428</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scalzo</surname><given-names>A.A.</given-names></name><name><surname>Lyons</surname><given-names>P.A.</given-names></name><name><surname>Fitzgerald</surname><given-names>N.A.</given-names></name><name><surname>Forbes</surname><given-names>C.A.</given-names></name><name><surname>Yokoyama</surname><given-names>W.M.</given-names></name><name><surname>Shellam</surname><given-names>G.R.</given-names></name></person-group><year>1995</year><article-title>Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1</article-title>.<source>Genomics.</source><volume>27</volume>:<fpage>435</fpage>&#x02013;<lpage>441</lpage><pub-id pub-id-type="pmid">7558024</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desrosiers</surname><given-names>M.P.</given-names></name><name><surname>Kielczewska</surname><given-names>A.</given-names></name><name><surname>Loredo-Osti</surname><given-names>J.C.</given-names></name><name><surname>Adam</surname><given-names>S.G.</given-names></name><name><surname>Makrigiannis</surname><given-names>A.P.</given-names></name><name><surname>Lemieux</surname><given-names>S.</given-names></name><name><surname>Pham</surname><given-names>T.</given-names></name><name><surname>Lodoen</surname><given-names>M.B.</given-names></name><name><surname>Morgan</surname><given-names>K.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name><name><surname>Vidal</surname><given-names>S.M.</given-names></name></person-group><year>2005</year><article-title>Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection</article-title>.<source>Nat. Genet.</source><volume>37</volume>:<fpage>593</fpage>&#x02013;<lpage>599</lpage><pub-id pub-id-type="pmid">15895081</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hengel</surname><given-names>H.</given-names></name><name><surname>Reusch</surname><given-names>U.</given-names></name><name><surname>Gutermann</surname><given-names>A.</given-names></name><name><surname>Ziegler</surname><given-names>H.</given-names></name><name><surname>Jonjic</surname><given-names>S.</given-names></name><name><surname>Lucin</surname><given-names>P.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>1999</year><article-title>Cytomegaloviral control of MHC class I function in the mouse</article-title>.<source>Immunol. Rev.</source><volume>168</volume>:<fpage>167</fpage>&#x02013;<lpage>176</lpage><pub-id pub-id-type="pmid">10399073</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>H.</given-names></name><name><surname>Thale</surname><given-names>R.</given-names></name><name><surname>Lucin</surname><given-names>P.</given-names></name><name><surname>Muranyi</surname><given-names>W.</given-names></name><name><surname>Flohr</surname><given-names>T.</given-names></name><name><surname>Hengel</surname><given-names>H.</given-names></name><name><surname>Farrell</surname><given-names>H.</given-names></name><name><surname>Rawlinson</surname><given-names>W.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>1997</year><article-title>A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments</article-title>.<source>Immunity.</source><volume>6</volume>:<fpage>57</fpage>&#x02013;<lpage>66</lpage><pub-id pub-id-type="pmid">9052837</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reusch</surname><given-names>U.</given-names></name><name><surname>Muranyi</surname><given-names>W.</given-names></name><name><surname>Lucin</surname><given-names>P.</given-names></name><name><surname>Burgert</surname><given-names>H.G.</given-names></name><name><surname>Hengel</surname><given-names>H.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>1999</year><article-title>A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation</article-title>.<source>EMBO J.</source><volume>18</volume>:<fpage>1081</fpage>&#x02013;<lpage>1091</lpage><pub-id pub-id-type="pmid">10022849</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleijnen</surname><given-names>M.F.</given-names></name><name><surname>Huppa</surname><given-names>J.B.</given-names></name><name><surname>Lucin</surname><given-names>P.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Farrell</surname><given-names>H.</given-names></name><name><surname>Campbell</surname><given-names>A.E.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name><name><surname>Hill</surname><given-names>A.B.</given-names></name><name><surname>Ploegh</surname><given-names>H.L.</given-names></name></person-group><year>1997</year><article-title>A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface</article-title>.<source>EMBO J.</source><volume>16</volume>:<fpage>685</fpage>&#x02013;<lpage>694</lpage><pub-id pub-id-type="pmid">9049298</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavanagh</surname><given-names>D.G.</given-names></name><name><surname>Gold</surname><given-names>M.C.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name><name><surname>Hill</surname><given-names>A.B.</given-names></name></person-group><year>2001</year><article-title>The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion</article-title>.<source>J. Exp. Med.</source><volume>194</volume>:<fpage>967</fpage>&#x02013;<lpage>978</lpage><pub-id pub-id-type="pmid">11581318</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>S.C.</given-names></name><name><surname>Schmader</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>T.T.</given-names></name><name><surname>Miller</surname><given-names>S.E.</given-names></name><name><surname>Howell</surname><given-names>D.N.</given-names></name><name><surname>Daley</surname><given-names>G.G.</given-names></name><name><surname>Hamilton</surname><given-names>J.D.</given-names></name></person-group><year>2000</year><article-title>Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection</article-title>.<source>J. Virol. Methods.</source><volume>89</volume>:<fpage>61</fpage>&#x02013;<lpage>73</lpage><pub-id pub-id-type="pmid">10996640</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Gutermann</surname><given-names>A.</given-names></name><name><surname>Podlech</surname><given-names>J.</given-names></name><name><surname>Reddehase</surname><given-names>M.J.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>2002</year><article-title>Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus</article-title>.<source>J. Exp. Med.</source><volume>196</volume>:<fpage>805</fpage>&#x02013;<lpage>816</lpage><pub-id pub-id-type="pmid">12235213</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimasi</surname><given-names>N.</given-names></name><name><surname>Biassoni</surname><given-names>R.</given-names></name></person-group><year>2005</year><article-title>Structural and functional aspects of the Ly49 natural killer cell receptors</article-title>.<source>Immunol. Cell Biol.</source><volume>83</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="pmid">15661035</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arase</surname><given-names>H.</given-names></name><name><surname>Mocarski</surname><given-names>E.S.</given-names></name><name><surname>Campbell</surname><given-names>A.E.</given-names></name><name><surname>Hill</surname><given-names>A.B.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><year>2002</year><article-title>Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors</article-title>.<source>Science.</source><volume>296</volume>:<fpage>1323</fpage>&#x02013;<lpage>1326</lpage><pub-id pub-id-type="pmid">11950999</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Kavanagh</surname><given-names>D.G.</given-names></name><name><surname>Hill</surname><given-names>A.B.</given-names></name></person-group><year>2006</year><article-title>Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules</article-title>.<source>J. Virol.</source><volume>80</volume>:<fpage>6048</fpage>&#x02013;<lpage>6055</lpage><pub-id pub-id-type="pmid">16731943</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtappels</surname><given-names>R.</given-names></name><name><surname>Gillert-Marien</surname><given-names>D.</given-names></name><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Podlech</surname><given-names>J.</given-names></name><name><surname>Deegen</surname><given-names>P.</given-names></name><name><surname>Herter</surname><given-names>S.</given-names></name><name><surname>Oehrlein-Karpi</surname><given-names>S.A.</given-names></name><name><surname>Strand</surname><given-names>D.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Reddehase</surname><given-names>M.J.</given-names></name></person-group><year>2006</year><article-title>Cytomegalovirus encodes a positive regulator of antigen presentation</article-title>.<source>J. Virol.</source><volume>80</volume>:<fpage>7613</fpage>&#x02013;<lpage>7624</lpage><pub-id pub-id-type="pmid">16840340</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Dighe</surname><given-names>A.</given-names></name><name><surname>Clark</surname><given-names>P.</given-names></name><name><surname>Sabastian</surname><given-names>P.</given-names></name><name><surname>Buss</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>M.G.</given-names></name></person-group><year>2007</year><article-title>Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins</article-title>.<source>J. Virol.</source><volume>81</volume>:<fpage>229</fpage>&#x02013;<lpage>236</lpage><pub-id pub-id-type="pmid">17050600</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L.M.</given-names></name><name><surname>Shellam</surname><given-names>G.R.</given-names></name><name><surname>Redwood</surname><given-names>A.J.</given-names></name></person-group><year>2006</year><article-title>Genes of murine cytomegalovirus exist as a number of distinct genotypes</article-title>.<source>Virology.</source><volume>352</volume>:<fpage>450</fpage>&#x02013;<lpage>465</lpage><pub-id pub-id-type="pmid">16781754</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L.M.</given-names></name><name><surname>McWhorter</surname><given-names>A.R.</given-names></name><name><surname>Masters</surname><given-names>L.L.</given-names></name><name><surname>Shellam</surname><given-names>G.R.</given-names></name><name><surname>Redwood</surname><given-names>A.J.</given-names></name></person-group><year>2008</year><article-title>Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus</article-title>.<source>J. Virol.</source><volume>82</volume>:<fpage>6689</fpage>&#x02013;<lpage>6696</lpage><pub-id pub-id-type="pmid">18417589</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>A.R.</given-names></name><name><surname>Pingel</surname><given-names>J.T.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Bubic</surname><given-names>I.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Koszinowski</surname><given-names>U.</given-names></name><name><surname>Jonjic</surname><given-names>S.</given-names></name><name><surname>Yokoyama</surname><given-names>W.M.</given-names></name></person-group><year>2004</year><article-title>Escape of mutant double-stranded DNA virus from innate immune control</article-title>.<source>Immunity.</source><volume>20</volume>:<fpage>747</fpage>&#x02013;<lpage>756</lpage><pub-id pub-id-type="pmid">15189739</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voigt</surname><given-names>V.</given-names></name><name><surname>Forbes</surname><given-names>C.A.</given-names></name><name><surname>Tonkin</surname><given-names>J.N.</given-names></name><name><surname>Degli-Esposti</surname><given-names>M.A.</given-names></name><name><surname>Smith</surname><given-names>H.R.</given-names></name><name><surname>Yokoyama</surname><given-names>W.M.</given-names></name><name><surname>Scalzo</surname><given-names>A.A.</given-names></name></person-group><year>2003</year><article-title>Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells</article-title>.<source>Proc. Natl. Acad. Sci. USA.</source><volume>100</volume>:<fpage>13483</fpage>&#x02013;<lpage>13488</lpage><pub-id pub-id-type="pmid">14597723</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbett</surname><given-names>A.J.</given-names></name><name><surname>Forbes</surname><given-names>C.A.</given-names></name><name><surname>Moro</surname><given-names>D.</given-names></name><name><surname>Scalzo</surname><given-names>A.A.</given-names></name></person-group><year>2007</year><article-title>Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes</article-title>.<source>J. Gen. Virol.</source><volume>88</volume>:<fpage>758</fpage>&#x02013;<lpage>769</lpage><pub-id pub-id-type="pmid">17325348</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcami</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>G.L.</given-names></name></person-group><year>1992</year><article-title>A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection</article-title>.<source>Cell.</source><volume>71</volume>:<fpage>153</fpage>&#x02013;<lpage>167</lpage><pub-id pub-id-type="pmid">1394428</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohm</surname><given-names>V.</given-names></name><name><surname>Simon</surname><given-names>C.O.</given-names></name><name><surname>Podlech</surname><given-names>J.</given-names></name><name><surname>Seckert</surname><given-names>C.K.</given-names></name><name><surname>Gendig</surname><given-names>D.</given-names></name><name><surname>Deegen</surname><given-names>P.</given-names></name><name><surname>Gillert-Marien</surname><given-names>D.</given-names></name><name><surname>Lemmermann</surname><given-names>N.A.</given-names></name><name><surname>Holtappels</surname><given-names>R.</given-names></name><name><surname>Reddehase</surname><given-names>M.J.</given-names></name></person-group><year>2008</year><article-title>The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation</article-title>.<source>J. Virol.</source><volume>82</volume>:<fpage>11637</fpage>&#x02013;<lpage>11650</lpage><pub-id pub-id-type="pmid">18815306</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashirova</surname><given-names>A.A.</given-names></name><name><surname>Martin</surname><given-names>M.P.</given-names></name><name><surname>McVicar</surname><given-names>D.W.</given-names></name><name><surname>Carrington</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense</article-title>.<source>Annu. Rev. Genomics Hum. Genet.</source><volume>7</volume>:<fpage>277</fpage>&#x02013;<lpage>300</lpage><pub-id pub-id-type="pmid">16824023</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brune</surname><given-names>W.</given-names></name><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Messerle</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>Manipulating cytomegalovirus genomes by BAC mutagenesis: strategies and applications.</article-title><comment><italic>In</italic></comment><article-title>Cytomegaloviruses Molecular Biology and Immunology.</article-title><person-group person-group-type="editor"><name><surname>Reddehase</surname><given-names>M.J.</given-names></name></person-group>, <edition>editor.</edition><publisher-name>Caister Academic Press</publisher-name>, <publisher-loc>Wymondham</publisher-loc><fpage>63</fpage>&#x02013;<lpage>89</lpage></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>M.</given-names></name><name><surname>Jonjic</surname><given-names>S.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name><name><surname>Messerle</surname><given-names>M.</given-names></name></person-group><year>1999</year><article-title>Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution</article-title>.<source>J. Virol.</source><volume>73</volume>:<fpage>7056</fpage>&#x02013;<lpage>7060</lpage><pub-id pub-id-type="pmid">10400809</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thale</surname><given-names>R.</given-names></name><name><surname>Szepan</surname><given-names>U.</given-names></name><name><surname>Hengel</surname><given-names>H.</given-names></name><name><surname>Geginat</surname><given-names>G.</given-names></name><name><surname>Lucin</surname><given-names>P.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>1995</year><article-title>Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport</article-title>.<source>J. Virol.</source><volume>69</volume>:<fpage>6098</fpage>&#x02013;<lpage>6105</lpage><pub-id pub-id-type="pmid">7666513</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddehase</surname><given-names>M.J.</given-names></name><name><surname>Weiland</surname><given-names>F.</given-names></name><name><surname>Munch</surname><given-names>K.</given-names></name><name><surname>Jonjic</surname><given-names>S.</given-names></name><name><surname>Luske</surname><given-names>A.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name></person-group><year>1985</year><article-title>Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs</article-title>.<source>J. Virol.</source><volume>55</volume>:<fpage>264</fpage>&#x02013;<lpage>273</lpage><pub-id pub-id-type="pmid">2991554</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>W.H.</given-names></name><name><surname>Rosen</surname><given-names>D.B.</given-names></name><name><surname>Arase</surname><given-names>H.</given-names></name><name><surname>Nixon</surname><given-names>D.F.</given-names></name><name><surname>Michaelsson</surname><given-names>J.</given-names></name><name><surname>Lanier</surname><given-names>L.L.</given-names></name></person-group><year>2007</year><article-title>Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation</article-title>.<source>J. Immunol.</source><volume>178</volume>:<fpage>647</fpage>&#x02013;<lpage>651</lpage><pub-id pub-id-type="pmid">17202323</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munks</surname><given-names>M.W.</given-names></name><name><surname>Gold</surname><given-names>M.C.</given-names></name><name><surname>Zajac</surname><given-names>A.L.</given-names></name><name><surname>Doom</surname><given-names>C.M.</given-names></name><name><surname>Morello</surname><given-names>C.S.</given-names></name><name><surname>Spector</surname><given-names>D.H.</given-names></name><name><surname>Hill</surname><given-names>A.B.</given-names></name></person-group><year>2006</year><article-title>Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus</article-title>.<source>J. Immunol.</source><volume>176</volume>:<fpage>3760</fpage>&#x02013;<lpage>3766</lpage><pub-id pub-id-type="pmid">16517745</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenac</surname><given-names>T.</given-names></name><name><surname>Budt</surname><given-names>M.</given-names></name><name><surname>Arapovic</surname><given-names>J.</given-names></name><name><surname>Hasan</surname><given-names>M.</given-names></name><name><surname>Zimmermann</surname><given-names>A.</given-names></name><name><surname>Simic</surname><given-names>H.</given-names></name><name><surname>Krmpotic</surname><given-names>A.</given-names></name><name><surname>Messerle</surname><given-names>M.</given-names></name><name><surname>Ruzsics</surname><given-names>Z.</given-names></name><name><surname>Koszinowski</surname><given-names>U.H.</given-names></name><etal/></person-group><year>2006</year><article-title>The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60</article-title>.<source>J. Exp. Med.</source><volume>203</volume>:<fpage>1843</fpage>&#x02013;<lpage>1850</lpage><pub-id pub-id-type="pmid">16831899</pub-id></mixed-citation></ref></ref-list></back></article>